Were Henry Gouws’s DRD share sales made under a Rule 10b5-1 trading plan?

No. The document-level checkbox for Rule 10b5-1 plans is not marked as affirmed, and the footnotes do not state that the transactions were made pursuant to a Rule 10b5-1 trading plan.

DRDGOLD officer sells 16,826 shares at about $2.75

Q: What insider transactions did DRD officer Henry Gouws report in this Form 4 for DRD?

He reported the vesting and settlement of 16,826 Deferred Shares into 16,826 Ordinary Shares on August 13, 2026, followed by sales of 16,826 Ordinary Shares in pooled transactions on August 31 and September 1, 2026.

Q: At what price were the DRD Ordinary Shares sold by Henry Gouws?

The filing reports an average sale price of $2.7545 per Ordinary Share, shown in U.S. dollars after conversion from South African rand, with an average rand price of ZAR 44.4764 per share based on the South African Reserve Bank exchange rate on the transaction date.

Q: How many DRD shares did Henry Gouws acquire through vesting before the sale?

On August 13, 2026, 16,826 Deferred Shares previously awarded under DRDGOLD’s Single Incentive Plan vested and were settled on a one-for-one basis into 16,826 Ordinary Shares for no consideration.

Q: What role does Henry Gouws hold at DRDGOLD LTD (DRD)?

Henry Gouws is identified as an officer of DRDGOLD, with the title Head of Production, Director of Ergo, in the reporting person information section of the Form 4.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

DRDGOLD LTD (DRD) reported that officer Henry Gouws, Head of Production and Director of Ergo, exercised and settled 16,826 Deferred Shares into the same number of Ordinary Shares on August 13, 2026 at no cost under the company’s Single Incentive Plan, then sold 16,826 Ordinary Shares in market transactions on August 31 and September 1, 2026 at an average price of about $2.75 per share, converted from South African rand. Following these transactions, he continues to hold 144,077 Deferred Shares. No Rule 10b5-1 trading plan is indicated.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Gouws Henry

Role Head of Prod., Dir. of Ergo

Sold 16,826 shs ($46K)

Approx. gross sale proceeds $46K

Approx. exercise cost $0.00

Type	Security	Shares	Price	Value
Sale	Ordinary Shares ^{F2, F3}	16,826	$2.7545	$46K
Exercise	Deferred Shares ^{F1, F4}	16,826	$0.00	$0.00
Exercise	Ordinary Shares ^F1	16,826	$0.00	$0.00

Holdings After Transaction: Deferred Shares — 144,077 contracts (Direct); Ordinary Shares — 3,050 shares (Direct)

Footnotes (4)

F1. On August 13, 2026, 16,826 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.
F2. Represents 16,826 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 16,826 Deferred Shares described in footnote 1.
F3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.
F4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.

Key Figures

Ordinary Shares sold: 16,826 shares Average sale price (USD): $2.7545 per share Average sale price (ZAR): ZAR 44.4764 per share +3 more

6 metrics

Ordinary Shares sold 16,826 shares Ordinary Shares sold in pooled transactions on August 31 and September 1, 2026

Average sale price (USD) $2.7545 per share Price per Ordinary Share reported after conversion from South African rand

Average sale price (ZAR) ZAR 44.4764 per share Average sale price in rand for the pooled Ordinary Share sale

Deferred Shares vested 16,826 shares Deferred Shares vested and settled into Ordinary Shares on August 13, 2026

Deferred Shares held after transaction 144,077 shares Current holdings of Deferred Shares reported in Table II, Column 9

Exercise price for Deferred Shares $0.00 per share Deferred Shares settled on a one-for-one basis in Ordinary Shares for no consideration

Key Terms

Deferred Shares, Single Incentive Plan, pooled sale, South African Reserve Bank exchange rate

4 terms

Deferred Shares financial

"16,826 deferred shares of DRDGOLD Limited previously awarded to the Reporting Person"

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

Single Incentive Plan financial

"previously awarded to the Reporting Person under the Company's Single Incentive Plan"

pooled sale financial

"sold on behalf of the Reporting Person as part of a pooled sale conducted"

South African Reserve Bank exchange rate financial

"converted from ZAR using the South African Reserve Bank exchange rate in effect"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did DRD officer Henry Gouws report in this Form 4 for DRD?

He reported the vesting and settlement of 16,826 Deferred Shares into 16,826 Ordinary Shares on August 13, 2026, followed by sales of 16,826 Ordinary Shares in pooled transactions on August 31 and September 1, 2026.

At what price were the DRD Ordinary Shares sold by Henry Gouws?

The filing reports an average sale price of $2.7545 per Ordinary Share, shown in U.S. dollars after conversion from South African rand, with an average rand price of ZAR 44.4764 per share based on the South African Reserve Bank exchange rate on the transaction date.

How many DRD shares did Henry Gouws acquire through vesting before the sale?

On August 13, 2026, 16,826 Deferred Shares previously awarded under DRDGOLD’s Single Incentive Plan vested and were settled on a one-for-one basis into 16,826 Ordinary Shares for no consideration.

How many DRD Deferred Shares does Henry Gouws hold after these transactions?

The filing states that Gouws’s current holdings of Deferred Shares are 144,077, as reflected in Table II, Column 9, after the vesting event and subsequent related updates described in the footnotes.

What role does Henry Gouws hold at DRDGOLD LTD (DRD)?

Henry Gouws is identified as an officer of DRDGOLD, with the title Head of Production, Director of Ergo, in the reporting person information section of the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/03/2026 - 05:02 PM EDT Accepted by SEC EDGAR 09/03/2026 - 04:56 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gouws Henry

(Last)

(First)

(Middle)

CYCAD HOUSE, BUILDING 17, GROUND FLOOR

CNR 14TH AVENUE AND HENDRIK POTGIETER RD

(Street)

WELTEVREDEN PARK

1709

(City)

(State)

(Zip)

SOUTH AFRICA

(Country)

2. Issuer Name and Ticker or Trading Symbol
DRDGOLD LTD [ DRD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Head of Prod., Dir. of Ergo

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	08/13/2026		M		16,826⁽¹⁾	A	$0	19,876	D
Ordinary Shares	09/01/2026		S		16,826⁽²⁾	D	$2.7545⁽³⁾	3,050	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Shares	$0	08/13/2026		M			16,826⁽¹⁾	⁽¹⁾	⁽¹⁾	Ordinary Shares	16,826	$0	144,077⁽⁴⁾	D

Explanation of Responses:

1. On August 13, 2026, 16,826 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.

2. Represents 16,826 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 16,826 Deferred Shares described in footnote 1.

3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.

4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.

Remarks:

	/s/ Henry Gouws	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR